Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.

Abstract:

:TNF-α, produced by most malignant cells, orchestrates the interplay between malignant cells and myeloid cells, which have been linked to tumor growth and metastasis. Although TNF-α can exist as one of two isoforms, a 26-kDa membrane tethered form (mTNF-α) or a soluble 17-kDa cytokine (sTNF-α), the vast majority of published studies have only investigated the biologic effects of the soluble form. We show for the first time that membrane and soluble isoforms have diametrically opposing effects on both tumor growth and myeloid content. Mouse lung and melanoma tumor lines expressing mTNF-α generated small tumors devoid of monocytes versus respective control lines or lines expressing sTNF-α. The lack of myeloid cells was due to a direct effect of mTNF-α on myeloid survival via induction of cell necrosis by increasing reactive oxygen species. Human non-small cell lung carcinoma expressed varying levels of both soluble and membrane TNF-α, and gene expression patterns favoring mTNF-α were predictive of improved lung cancer survival. These data suggest that there are significant differences in the role of different TNF-α isoforms in tumor progression and the bioavailability of each isoform may distinctly regulate tumor progression. This insight is critical for effective intervention in cancer therapy with the available TNF-α inhibitors, which can block both TNF-α isoforms.

journal_name

Cancer Res

journal_title

Cancer research

authors

Ardestani S,Li B,Deskins DL,Wu H,Massion PP,Young PP

doi

10.1158/0008-5472.CAN-13-0002

subject

Has Abstract

pub_date

2013-07-01 00:00:00

pages

3938-50

issue

13

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-13-0002

journal_volume

73

pub_type

杂志文章
  • Effect of gestational development of lung tumor size and morphology in the mouse.

    abstract::Pregnant C3HeB/FeJ mice were treated with ethylnitrosourea (ENU) on one of gestation Days 10, 13, or 15 to determine if ENU treatment at different stages of gestation would result in qualitative or quantitative differences in lung tumors induced in the offspring. Lung tumors were counted and measured 6 mo after treatm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Branstetter DG,Stoner GD,Budd C,Conran PB,Goldblatt PJ

    更新日期:1988-01-15 00:00:00

  • Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.

    abstract::cis-Platinum, bleomycin, 5-fluorouracil, and cyclophosphamide were administered to rodent and canine models of osmotic blood-brain barrier modification to evaluate the relationship between tissue drug concentration in brain and the physiological and neuropathological effects of the drug. The toxicity studies were carr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Neuwelt EA,Barnett PA,Glasberg M,Frenkel EP

    更新日期:1983-11-01 00:00:00

  • A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization.

    abstract::Angiogenesis is one of the crucial events for cancer development and growth. Two members of the vascular endothelial growth factor (VEGF) family, VEGF-A and placental growth factor (PlGF), which are able to heterodimerize if coexpressed in the same cell, are both required for pathologic angiogenesis. We have generated...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2609

    authors: Tarallo V,Vesci L,Capasso O,Esposito MT,Riccioni T,Pastore L,Orlandi A,Pisano C,De Falco S

    更新日期:2010-03-01 00:00:00

  • Androgen dependency of a tumor produced by a cell line derived from androgen-responsive Shionogi carcinoma 115.

    abstract::An androgen-dependent tumor (SCC8 tumor) was obtained by inoculating an androgen-responsive cell line derived from the androgen-responsive Shionogi carcinoma 115 (SC115) into mice and then treating the mice with testosterone propionate (TP) at a pharmacological dose (400 micrograms/day). The SCC8 tumor differed in his...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Terada N,Yamamoto R,Uchida N,Takada T,Taniguchi H,Takatsuka D,Sawada M,Tsuji M,Li W,Kitamura Y

    更新日期:1989-02-01 00:00:00

  • Biological behavior of malignant melanoma cells correlated to their survival in vivo.

    abstract::Successive B16 melanoma tumor lines were selected for their ability to form pulmonary tumor nodules. This was accomplished by injecting tumor cells i.v. into syngeneic C57BL/6 mice and 2 to 3 weeks later collecting the secondary tumor growths and placing them into tissue culture. These tumor cells were then injected i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fidler IJ

    更新日期:1975-01-01 00:00:00

  • Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2.

    abstract::It has been shown that the systemic administration of lymphokine-activated killer (LAK) cells with recombinant interleukin 2 (RIL-2) is effective in reducing the number of established pulmonary and hepatic metastases in murine models. Similarly, this modality of therapy has been proven effective against certain select...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lafreniere R,Borkenhagen K,Bryant LD,Huchcroft S

    更新日期:1989-05-01 00:00:00

  • Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

    abstract::Photodynamic therapy (PDT) is now an approved therapeutic modality, and induction of vascular endothelial growth factor (VEGF) following subcurative PDT is of concern as VEGF may provide a survival stimulus to tumors. The processes that limit the efficacy of PDT warrant investigation so that mechanism-based interventi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0604

    authors: Solban N,Selbo PK,Sinha AK,Chang SK,Hasan T

    更新日期:2006-06-01 00:00:00

  • Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.

    abstract::A mammalian cell expression plasmid, pH beta-Aro, containing the human placenta aromatase complementary DNA was constructed. The prepared plasmid was used to transfect breast cancer cells (MCF-7), noncancerous breast cells (HBL-100), and Chinese hamster ovary cells by a stable expression method. While the maximum velo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhou DJ,Pompon D,Chen SA

    更新日期:1990-11-01 00:00:00

  • [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.

    abstract::[D-Arg1,D-Trp5,7,9,Leu11]Substance P (SP) was identified out of a panel of novel SP analogues as the most potent inhibitor of small cell lung cancer (SCLC) cell growth. This analogue inhibited proliferation of H-510 and H-69 SCLC cells in liquid culture and in semisolid media (IC50, 5 microM). Colony formation stimula...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Seckl MJ,Higgins T,Widmer F,Rozengurt E

    更新日期:1997-01-01 00:00:00

  • Role of the prostaglandin E2 receptor in mammary tumor metastasis.

    abstract::Both clinical and experimental breast tumors often synthesize high levels of prostaglandins, most notably prostaglandin E2 (PGE2). We have reported previously that metastatic murine mammary tumor cells also express a high-affinity PGE2 receptor. We have now shown that the receptor plays a functional role in the metast...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fulton AM,Zhang SZ,Chong YC

    更新日期:1991-04-15 00:00:00

  • Single-strand DNA-binding protein SSB1 facilitates TERT recruitment to telomeres and maintains telomere G-overhangs.

    abstract::Proliferating mammalian stem and cancer cells express telomerase [telomerase reverse transcriptase (TERT)] in an effort to extend chromosomal G-overhangs and maintain telomere ends. Telomerase-expressing cells also have higher levels of the single-stranded DNA-binding protein SSB1, which has a critical role in DNA dou...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2289

    authors: Pandita RK,Chow TT,Udayakumar D,Bain AL,Cubeddu L,Hunt CR,Shi W,Horikoshi N,Zhao Y,Wright WE,Khanna KK,Shay JW,Pandita TK

    更新日期:2015-03-01 00:00:00

  • Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.

    abstract::Retinoic acid receptors and retinoid X receptors form heterodimers, bind to retinoic acid response elements, and transactivate the transcription of retinoid-responsive genes. Two synthetic retinoids [4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (TTAB) and 6-(5,6,7,8-tetrahydro-5,5,8,8-tetrameth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lotan R,Dawson MI,Zou CC,Jong L,Lotan D,Zou CP

    更新日期:1995-01-15 00:00:00

  • Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors.

    abstract::Heparin-binding polypeptide growth factors (HBGF) are essential mitogens for isolated prostate cells. HBGF type one (HBGF-1) mRNA was expressed specifically in the epithelial cells of prostates from normal 6- to 8-week-old rats. Expression declined significantly at 14 weeks and was undetectable in 35-week-old animals....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mansson PE,Adams P,Kan M,McKeehan WL

    更新日期:1989-05-01 00:00:00

  • A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.

    abstract::AS1411 is a first-in-class anticancer agent, currently in phase II clinical trials. It is a quadruplex-forming oligodeoxynucleotide that binds to nucleolin as an aptamer, but its mechanism of action is not completely understood. Mechanistic insights could lead to clinically useful markers for AS1411 response and to no...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0920

    authors: Reyes-Reyes EM,Teng Y,Bates PJ

    更新日期:2010-11-01 00:00:00

  • Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in Saccharomyces cerevisiae.

    abstract::The peroxiredoxins (Prx) are conserved antioxidant proteins that use cysteine as the primary site of oxidation during the reduction of peroxides. Many organisms have more than one isoform of Prx. Deletion of TSA1, one of five Prxs in yeast Saccharomyces cerevisiae, results in accumulation of a broad spectrum of mutati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2683

    authors: Iraqui I,Faye G,Ragu S,Masurel-Heneman A,Kolodner RD,Huang ME

    更新日期:2008-02-15 00:00:00

  • Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.

    abstract::Cisplatin (cis-diamminedichloroplatinum, CDDP) is one of the most used drugs for osteosarcoma chemotherapy. By using a series of CDDP-resistant variants, which were established from the U-2OS and Saos-2 human osteosarcoma cell lines, we found that CDDP resistance was mainly associated with the increase of both the int...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5840

    authors: Pasello M,Michelacci F,Scionti I,Hattinger CM,Zuntini M,Caccuri AM,Scotlandi K,Picci P,Serra M

    更新日期:2008-08-15 00:00:00

  • Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia.

    abstract::Low-density lipoprotein (LDL) could be used as a carrier of chemotherapeutic agents to neoplastic cells that overexpress LDL receptors (rLDL), but LDL is difficult to obtain and handle. Recently, it was observed that a protein-free emulsion resembling the lipid portion of LDL (LDE) behave like native LDL when injected...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Maranhão RC,Garicochea B,Silva EL,Dorlhiac-Llacer P,Cadena SM,Coelho IJ,Meneghetti JC,Pileggi FJ,Chamone DA

    更新日期:1994-09-01 00:00:00

  • Secretion of a cysteine proteinase from a hormone-independent cell population of cultured explants of murine mammary gland.

    abstract::Cultured explants of mouse mammary gland were investigated for their capacity to secrete a cathepsin B-like cysteine proteinase. This enzyme had been shown previously to be secreted excessively from cultured explants of human breast tumors and spontaneous mouse mammary carcinomas. We now show that secretion is also ob...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Recklies AD,White C,Mitchell J,Poole AR

    更新日期:1985-05-01 00:00:00

  • Invasive properties of primary pediatric neoplasms in vitro.

    abstract::Primary solid tumors were mechanically and/or enzymatically disassociated, and the resulting suspensions of single cells and small clumps of cells were seeded onto three different substrates, i.e., tissue culture plastic, rat smooth muscle cells (SMCs), and SMC-derived extracellular matrix. Tests of the relative effec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bogenmann E,Mark C,Isaacs H,Neustein HB,De Clerck YA,Laug WE,Jones PA

    更新日期:1983-03-01 00:00:00

  • Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas.

    abstract::The epidermal growth factor (EGF) receptor in two colon carcinoma lines and in one vulval carcinoma line tested contains carbohydrate determinants that are recognized by monoclonal antibodies to tumor-associated antigens. These antibodies are directed to sialylated Lea and to difucosylated structures of the Y type. Ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Basu A,Murthy U,Rodeck U,Herlyn M,Mattes L,Das M

    更新日期:1987-05-15 00:00:00

  • Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.

    abstract::In vitro cell-mediated cytotoxicity (CMC) assays have been carried out in human melanoma system with blood effector lymphocytes on [3H]proline-labeled target cells in a 48-hr microcytotoxicity technique. Three lymphocyte purification procedures (Ficoll:Hypaque gradient, plasma gel sedimentation followed by nylon colum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mukherji B,Vassos D,Flowers A,Binder SC,Nathanson L

    更新日期:1975-12-01 00:00:00

  • The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.

    abstract::The interleukin-11 receptor alpha (IL-11Ralpha) is a functional target in bone metastasis. However, its role in primary bone tumors has not been established. As such, here, we evaluated IL-11Ralpha as a candidate target in primary and metastatic human osteosarcoma. First, in an orthotopic mouse model, we showed that I...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4845

    authors: Lewis VO,Ozawa MG,Deavers MT,Wang G,Shintani T,Arap W,Pasqualini R

    更新日期:2009-03-01 00:00:00

  • Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.

    abstract::The role of angiogenesis inhibition in the antitumor activity of recombinant murine interleukin 12 (rmIL-12) was studied in K1735 murine melanomas, the growth of which is rapidly and markedly suppressed by rmIL-12 treatment. On the basis of the prediction that tumor ischemia should result from therapeutic angiogenesis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gee MS,Koch CJ,Evans SM,Jenkins WT,Pletcher CH Jr,Moore JS,Koblish HK,Lee J,Lord EM,Trinchieri G,Lee WM

    更新日期:1999-10-01 00:00:00

  • Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.

    abstract::CD38 is a leukocyte differentiation antigen that has been thought to be a phenotypic marker of different subpopulations of T- and B-lymphocytes. In myeloid cells, CD38 is expressed during early stages of differentiation. Virtually no information is available on regulation and functions of CD38. Recently we reported th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Drach J,McQueen T,Engel H,Andreeff M,Robertson KA,Collins SJ,Malavasi F,Mehta K

    更新日期:1994-04-01 00:00:00

  • Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.

    abstract::8-Carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H) -one (mitozolomide) demonstrates curative action against a range of murine tumor model systems. At single doses of between 20 and 40 mg/kg, the latter of which approximates the 10% lethal dose value in mice, the compound elicited cures against the L121...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hickman JA,Stevens MF,Gibson NW,Langdon SP,Fizames C,Lavelle F,Atassi G,Lunt E,Tilson RM

    更新日期:1985-07-01 00:00:00

  • Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.

    abstract::The invasive transformation of A-459 lung epithelial carcinoma cells has been linked to the autocrine regulation of malignant phenotypic changes by transforming growth factor beta (TGF-beta). Here we demonstrate, using stable 13C glucose isotopes, that the transformed phenotype is characterized by decreased CO2 produc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Boros LG,Torday JS,Lim S,Bassilian S,Cascante M,Lee WN

    更新日期:2000-03-01 00:00:00

  • Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

    abstract::Lymphangioleiomyomatosis (LAM) is a progressive destructive neoplasm of the lung associated with inactivating mutations in the TSC1 or TSC2 tumor suppressor genes. Cell or animal models that accurately reflect the pathology of LAM have been challenging to develop. Here, we generated a robust human cell model of LAM by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0925

    authors: Julian LM,Delaney SP,Wang Y,Goldberg AA,Doré C,Yockell-Lelièvre J,Tam RY,Giannikou K,McMurray F,Shoichet MS,Harper ME,Henske EP,Kwiatkowski DJ,Darling TN,Moss J,Kristof AS,Stanford WL

    更新日期:2017-10-15 00:00:00

  • Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

    abstract::PD115934 (NSC 366140) is a soluble pyrazoloacridine derivative presently undergoing preclinical toxicology evaluation with the anticipation of Phase I human investigation. The agent displayed both human and murine solid tumor selectivity in vitro in a soft agar disk diffusion assay, relative to its activity against mu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: LoRusso P,Wozniak AJ,Polin L,Capps D,Leopold WR,Werbel LM,Biernat L,Dan ME,Corbett TH

    更新日期:1990-08-15 00:00:00

  • Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.

    abstract::It is fairly well accepted that the presence of estrogen receptor (ER) and progesterone receptor (PgR) identifies breast cancer patients with a lower risk of relapse and better overall survival. But patients with discordant receptors, the ER+/PgR- phenotype, are often intermediate in clinical response. We focused upon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fuqua SA,Fitzgerald SD,Allred DC,Elledge RM,Nawaz Z,McDonnell DP,O'Malley BW,Greene GL,McGuire WL

    更新日期:1992-01-15 00:00:00

  • Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.

    abstract::The ability of the vitamin E (RRR-alpha-tocopherol) derivatives alpha-tocopheryl succinate (alpha-TOS) and alpha-tocopheryloxyacetic acid (alpha-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2403

    authors: Hahn T,Szabo L,Gold M,Ramanathapuram L,Hurley LH,Akporiaye ET

    更新日期:2006-10-01 00:00:00